Lenzetto

Estradiol, the active ingredient in Lenzetto, is an estrogen presented as a transdermal patch for transdermal use. It treats estrogen deficiency and related menopausal symptoms, including hot flashes, night sweats, and bone loss, in postmenopausal women. The patch provides steady systemic absorption, avoiding first‑pass metabolism and offering convenient once‑weekly application.

GNH USA supplies Lenzetto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity across global markets. Our supply chain adheres to WHO‑GMP standards, and we support regulatory documentation, customs clearance, and temperature‑controlled logistics for all shipments.

Lenzetto, an estradiol transdermal system, is used in hormone‑replacement therapy to address estrogen‑related conditions.

- Relief of moderate to severe vasomotor symptoms associated with menopause: reduces hot flashes and night sweats. - Prevention of osteoporosis in postmenopausal women: helps maintain bone mineral density. - Treatment of estrogen deficiency: restores physiological estrogen levels in women with hypoestrogenism.

Common Side Effects: - Skin irritation at the application site: redness, itching, or rash. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Breast tenderness: mild discomfort. - Mood changes: irritability or emotional lability. - Fluid retention: mild swelling of ankles or feet.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Myocardial infarction: heart attack risk. - Hepatic dysfunction: abnormal liver enzymes. - Severe allergic reaction: anaphylaxis or angioedema. - Endometrial hyperplasia or carcinoma: abnormal uterine bleeding.

Before initiating therapy, consider the following precautions.

- Assess cardiovascular risk: evaluate history of thromboembolism or clotting disorders. - Screen for hormone‑sensitive cancers: avoid use in active breast or endometrial cancer. - Monitor blood pressure: watch for hypertension or fluid retention. - Consider liver function: use cautiously in patients with hepatic impairment. - Store at room temperature: keep patch in original packaging, protect from moisture and direct heat.

Estradiol may interact with several drug classes; monitor patients accordingly.

Major Interactions (Avoid): - Combined estrogen‑progestin oral contraceptives: increased risk of thromboembolic events. - Warfarin: potential enhancement of anticoagulant effect. - Tamoxifen: antagonizes estrogenic activity, reducing therapeutic benefit.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible alteration of blood pressure control. - Lithium: estradiol may increase serum lithium concentrations. - SSRIs (e.g., paroxetine): may diminish efficacy for hot‑flash relief.